PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12126473-0	2002	Influence of platelet-activating factor, its cell analogs, and antagonist on the production of superoxide radicals by blood leukocytes of healthy and hypercholesterolemic individuals.	Superoxides	95-105	PCNA clamp associated factor	Homo sapiens	13-39	
12126473-1	2002	The influence of the phospholipid platelet-activating factor (PAF), its cell analogs, and lipid PAF antagonist on the production of superoxide radicals by leukocytes isolated from the blood of healthy and hypercholesterolemia IIA individuals was studied.	Superoxides	132-142	PCNA clamp associated factor	Homo sapiens	62-65	
12126473-1	2002	The influence of the phospholipid platelet-activating factor (PAF), its cell analogs, and lipid PAF antagonist on the production of superoxide radicals by leukocytes isolated from the blood of healthy and hypercholesterolemia IIA individuals was studied.	Superoxides	132-142	PCNA clamp associated factor	Homo sapiens	96-99	
12126473-3	2002	Exogenous PAF stimulates the superoxide production in the leukocytes of healthy individuals but significantly inhibits the superoxide production in the leukocytes of hypercholesterolemic individuals.	Superoxides	29-39	PCNA clamp associated factor	Homo sapiens	10-13	
12126473-3	2002	Exogenous PAF stimulates the superoxide production in the leukocytes of healthy individuals but significantly inhibits the superoxide production in the leukocytes of hypercholesterolemic individuals.	Superoxides	123-133	PCNA clamp associated factor	Homo sapiens	10-13	
12126473-5	2002	However, pretreatment of leukocytes by 1-alkenyl-PAF or PAF-antagonist (1-O-alk-1;-enyl-2-(2;-acetoxybenzoyl)-sn-glycero-3-phosphocholine) results in a 50% inhibition of the PAF-induced superoxide production by leukocytes of healthy individuals.	Superoxides	186-196	PCNA clamp associated factor	Homo sapiens	56-59	
12126473-5	2002	However, pretreatment of leukocytes by 1-alkenyl-PAF or PAF-antagonist (1-O-alk-1;-enyl-2-(2;-acetoxybenzoyl)-sn-glycero-3-phosphocholine) results in a 50% inhibition of the PAF-induced superoxide production by leukocytes of healthy individuals.	Superoxides	186-196	PCNA clamp associated factor	Homo sapiens	56-59	
12126473-6	2002	This PAF-antagonist alone or in combination with PAF induces a substantial (65-70%) inhibition of superoxide production in the leukocytes of hypercholesterolemic individuals.	Superoxides	98-108	PCNA clamp associated factor	Homo sapiens	5-8	
12126473-6	2002	This PAF-antagonist alone or in combination with PAF induces a substantial (65-70%) inhibition of superoxide production in the leukocytes of hypercholesterolemic individuals.	Superoxides	98-108	PCNA clamp associated factor	Homo sapiens	49-52	
12126473-7	2002	It is concluded that superoxide production by leukocytes of healthy individuals and especially by leukocytes of hypercholesterolemic individuals is process that depends on PAF or PAF-like lipids.	Superoxides	21-31	PCNA clamp associated factor	Homo sapiens	172-175	
12126473-7	2002	It is concluded that superoxide production by leukocytes of healthy individuals and especially by leukocytes of hypercholesterolemic individuals is process that depends on PAF or PAF-like lipids.	Superoxides	21-31	PCNA clamp associated factor	Homo sapiens	179-182